Abstract | PURPOSE: The systemic inflammatory response is attracting increasing attention as a predictive biomarker for oncological outcome in patients with colorectal cancer. This study is aimed at verifying if the lymphocyte- C-reactive protein (CRP) ratio (LCR) could be used as a predictor of oncological outcome in patients with rectal cancer (RC) receiving preoperative chemoradiotherapy (CRT). METHODS: We analyzed data for 86 patients with RC who received preoperative CRT followed by total mesorectal excision at our institution. A ratio of 6000 was used as the cut-off value for LCR for further analysis. RESULTS: The post-CRT LCR was significantly lower than the pre-CRT LCR in patients with RC. Although post-CRT LCR status was not significantly correlated with overall survival (OS), low pre-CRT LCR was significantly associated with shorter recurrence-free survival (RFS: p = 0.02) and OS (p = 0.017) in this population and was an independent prognostic factor for both RFS and OS (hazard ratio (HR) 3.19, 95% confidence interval (CI) 1.33-7.66, p = 0.009; HR 2.83, 95%CI 1.14-7.01, p = 0.025, respectively). Furthermore, low pre-CRT LCR was a stronger indicator of early recurrence (p = 0.001) and poor prognosis (p = 0.025) in RC patients without pathological lymph node metastasis compared with patients with pathological lymph node metastasis, and prognostic potential of pre-CRT LCR was clearly revealed especially RC patients receiving long-course CRT. CONCLUSIONS: Assessment of pretreatment LCR status might aid decision-making regarding postoperative treatment strategies in patients with RC receiving CRT followed by potentially curative resection.
|
Authors | Yoshinaga Okugawa, Yuji Toiyama, Hiroyuki Fujikawa, Shozo Ide, Akira Yamamoto, Yusuke Omura, Chengzeng Yin, Kurando Kusunoki, Yukina Kusunoki, Hiromi Yasuda, Takeshi Yokoe, Junichiro Hiro, Masaki Ohi, Masato Kusunoki |
Journal | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
(J Gastrointest Surg)
Vol. 25
Issue 2
Pg. 492-502
(02 2021)
ISSN: 1873-4626 [Electronic] United States |
PMID | 32040814
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- C-Reactive Protein
- Chemoradiotherapy
- Disease-Free Survival
- Humans
- Lymphocytes
(pathology)
- Neoadjuvant Therapy
- Neoplasm Staging
- Prognosis
- Rectal Neoplasms
(pathology)
- Retrospective Studies
|